Ozal A. Beylerli
6 Miklukho Maklaya St
Moscow, MOW 117198, Russian Federation
Moscow, MOW 117198, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Non-Coding RNAs and Common Neurosurgical Conditions: A Key to Future Personalized Molecular Therapy.
Non-Coding RNAs and Common Neurosurgical Conditions: A Key to Future Personalized Molecular Therapy.
Journal: Current medicinal chemistry
Published: March 17, 2026
Unlocking the Prognostic Power of the m-CALLY Index in Cardiovascular-Kidney-Metabolic Syndrome.
Journal: Current medicinal chemistry
Published: September 28, 2025
Nephroprotective Effects of Silymarin: A Systematic Review and Meta-Analysis.
Journal: Biochemistry. Biokhimiia
Published: August 31, 2025
Immune Cell Infiltration and Key Gene Identification in Alzheimer's Disease and Sleep Deprivation.
Journal: CNS & neurological disorders drug targets
Published: May 13, 2025
Uncovering the oxidative stress and hematological consequences of chronic cobalt exposure on atherosclerosis.
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Published: May 08, 2025
Correction: Beylerli et al. MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary Adenomas. Int. J. Mol. Sci. 2020, 21, 7287.
Journal: International journal of molecular sciences
Published: April 18, 2025
Hemorrhagic and ischemic risks of anti-VEGF therapies in glioblastoma.
Journal: Cancer gene therapy
Published: February 25, 2025
Identify Key Genes and Construct the lncRNA-miRNA-mRNA Regulatory Networks Associated with Glioblastoma by Bioinformatics Analysis.
Journal: Current medicinal chemistry
Published: December 08, 2024
New approaches to targeted drug therapy of intracranial tumors.
Journal: Cell death discovery
Published: November 20, 2024
Long Non-coding RNAs as Key Modulators in Hypoxic-Ischemic Brain Injury: Implications for Neuroprotection.
Journal: Current pharmaceutical design
Published: November 14, 2024
Angiogenesis and Resistance Mechanisms in Glioblastoma: Targeting Alternative Vascularization Pathways to Overcome Therapy Resistance.
Journal: Current pharmaceutical design
Published: November 11, 2024
Non-coding RNAs-based Therapy and Angiogenesis: A New Era for the Management of Gliomas.
Journal: Current gene therapy
Published: September 30, 2024
Last Updated: 09/26/2026